1578 related articles for article (PubMed ID: 28840552)
1. The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma.
Alaaeddine R; Fayad M; Nehme E; Bahmad HF; Kobeissy F
Adv Exp Med Biol; 2017; 1007():59-70. PubMed ID: 28840552
[TBL] [Abstract][Full Text] [Related]
2. Neuroproteomics Studies: Challenges and Updates.
Ramadan N; Ghazale H; El-Sayyad M; El-Haress M; Kobeissy FH
Methods Mol Biol; 2017; 1598():3-19. PubMed ID: 28508355
[TBL] [Abstract][Full Text] [Related]
3. Neuroproteomics approach and neurosystems biology analysis: ROCK inhibitors as promising therapeutic targets in neurodegeneration and neurotrauma.
Raad M; El Tal T; Gul R; Mondello S; Zhang Z; Boustany RM; Guingab J; Wang KK; Kobeissy F
Electrophoresis; 2012 Dec; 33(24):3659-68. PubMed ID: 23161464
[TBL] [Abstract][Full Text] [Related]
4. Neuroproteomics in neurotrauma.
Ottens AK; Kobeissy FH; Golden EC; Zhang Z; Haskins WE; Chen SS; Hayes RL; Wang KK; Denslow ND
Mass Spectrom Rev; 2006; 25(3):380-408. PubMed ID: 16498609
[TBL] [Abstract][Full Text] [Related]
5. Advances in neuroproteomics for neurotrauma: unraveling insights for personalized medicine and future prospects.
Kobeissy F; Goli M; Yadikar H; Shakkour Z; Kurup M; Haidar MA; Alroumi S; Mondello S; Wang KK; Mechref Y
Front Neurol; 2023; 14():1288740. PubMed ID: 38073638
[TBL] [Abstract][Full Text] [Related]
6. Glycomic and Glycoproteomic Techniques in Neurodegenerative Disorders and Neurotrauma: Towards Personalized Markers.
Kobeissy F; Kobaisi A; Peng W; Barsa C; Goli M; Sibahi A; El Hayek S; Abdelhady S; Ali Haidar M; Sabra M; Orešič M; Logroscino G; Mondello S; Eid AH; Mechref Y
Cells; 2022 Feb; 11(3):. PubMed ID: 35159390
[TBL] [Abstract][Full Text] [Related]
7. Dissecting Alzheimer's Disease Molecular Substrates by Proteomics and Discovery of Novel Post-translational Modifications.
Deolankar SC; Patil AH; Koyangana SG; Subbannayya Y; Prasad TSK; Modi PK
OMICS; 2019 Jul; 23(7):350-361. PubMed ID: 31225774
[TBL] [Abstract][Full Text] [Related]
8. Neuroproteomics tools in clinical practice.
Shevchenko G; Konzer A; Musunuri S; Bergquist J
Biochim Biophys Acta; 2015 Jul; 1854(7):705-17. PubMed ID: 25680928
[TBL] [Abstract][Full Text] [Related]
9. Proteomics and personalized medicine: a focus on kidney disease.
Siwy J; Mischak H; Zürbig P
Expert Rev Proteomics; 2019 Sep; 16(9):773-782. PubMed ID: 31441341
[No Abstract] [Full Text] [Related]
10. Advancing translational research and precision medicine with targeted proteomics.
Uzozie AC; Aebersold R
J Proteomics; 2018 Oct; 189():1-10. PubMed ID: 29476807
[TBL] [Abstract][Full Text] [Related]
11. The Potential of Proteomics in Understanding Neurodegeneration.
Pal R; Larsen JP; Moller SG
Int Rev Neurobiol; 2015; 121():25-58. PubMed ID: 26315761
[TBL] [Abstract][Full Text] [Related]
12. Role of Proteomics in the Development of Personalized Medicine.
Jain KK
Adv Protein Chem Struct Biol; 2016; 102():41-52. PubMed ID: 26827601
[TBL] [Abstract][Full Text] [Related]
13. Personalized medicine beyond genomics: alternative futures in big data-proteomics, environtome and the social proteome.
Özdemir V; Dove ES; Gürsoy UK; Şardaş S; Yıldırım A; Yılmaz ŞG; Ömer Barlas I; Güngör K; Mete A; Srivastava S
J Neural Transm (Vienna); 2017 Jan; 124(1):25-32. PubMed ID: 26645377
[TBL] [Abstract][Full Text] [Related]
14. Role of Systems Biology in Brain Injury Biomarker Discovery: Neuroproteomics Application.
Jaber Z; Aouad P; Al Medawar M; Bahmad H; Abou-Abbass H; Ghandour H; Mondello S; Kobeissy F
Methods Mol Biol; 2016; 1462():157-74. PubMed ID: 27604718
[TBL] [Abstract][Full Text] [Related]
15. [OMICS AND BIG DATA, MAJOR ADVANCES TOWARDS PERSONALIZED MEDICINE OF THE FUTURE?].
Scheen AJ
Rev Med Liege; 2015; 70(5-6):262-8. PubMed ID: 26285450
[TBL] [Abstract][Full Text] [Related]
16. Next-Generation Sequencing: The Translational Medicine Approach from "Bench to Bedside to Population".
Beigh MM
Medicines (Basel); 2016 Jun; 3(2):. PubMed ID: 28930123
[TBL] [Abstract][Full Text] [Related]
17. Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases.
La Cognata V; Morello G; Cavallaro S
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062930
[TBL] [Abstract][Full Text] [Related]
18. TBI Rehabilomics Research: an Exemplar of a Biomarker-Based Approach to Precision Care for Populations with Disability.
Wagner AK
Curr Neurol Neurosci Rep; 2017 Sep; 17(11):84. PubMed ID: 28929311
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics: Driving Personalized Medicine.
Sadee W; Wang D; Hartmann K; Toland AE
Pharmacol Rev; 2023 Jul; 75(4):789-814. PubMed ID: 36927888
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
